Arovella Therapeutics Limited (ASX: ALA)
Australia
· Delayed Price · Currency is AUD 0.180
-0.005 (-2.70%)
Nov 21, 2024, 4:10 PM AEST
Arovella Therapeutics Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Net Income | -8.75 | -8.75 | -10.18 | -8.62 | -5.05 | -9.94 | Upgrade
|
| Depreciation & Amortization | 0.04 | 0.04 | 0.14 | 0.2 | 0.2 | 0.22 | Upgrade
|
| Other Amortization | - | - | 0.69 | 0.36 | 0.45 | 0.35 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 1.56 | 0.85 | 1.25 | 5.94 | Upgrade
|
| Stock-Based Compensation | 1.05 | 1.05 | 0.87 | 0.58 | 0.04 | 0.09 | Upgrade
|
| Other Operating Activities | 0.1 | 0.1 | 0.01 | 0.44 | 0.02 | -0.06 | Upgrade
|
| Change in Accounts Receivable | -0.01 | -0.01 | 0.03 | 0.5 | 0.34 | 0.25 | Upgrade
|
| Change in Accounts Payable | 0.58 | 0.58 | 0.22 | -0.27 | -0.45 | 0.56 | Upgrade
|
| Change in Other Net Operating Assets | 0.07 | 0.07 | 0.26 | -0.3 | -0.34 | -0.31 | Upgrade
|
| Operating Cash Flow | -6.91 | -6.91 | -6.4 | -6.27 | -3.54 | -2.88 | Upgrade
|
| Capital Expenditures | -0.13 | -0.13 | -0 | -0.04 | -0.17 | -0.14 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.1 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | -0.53 | -0.35 | -0.25 | Upgrade
|
| Other Investing Activities | -0.05 | -0.05 | - | - | - | - | Upgrade
|
| Investing Cash Flow | -0.18 | -0.18 | 0.1 | -0.57 | -0.51 | -0.39 | Upgrade
|
| Long-Term Debt Repaid | - | - | -0.07 | -0.07 | -0.06 | -0.06 | Upgrade
|
| Total Debt Repaid | - | - | -0.07 | -0.07 | -0.06 | -0.06 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | -0.07 | -0.07 | -0.06 | -0.06 | Upgrade
|
| Issuance of Common Stock | 15.17 | 15.17 | - | 6.26 | 10.58 | - | Upgrade
|
| Other Financing Activities | -0.56 | -0.56 | 5.48 | - | -0.72 | - | Upgrade
|
| Financing Cash Flow | 14.61 | 14.61 | 5.41 | 6.19 | 9.8 | -0.06 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.02 | 0.02 | - | - | - | - | Upgrade
|
| Net Cash Flow | 7.54 | 7.54 | -0.9 | -0.65 | 5.74 | -3.34 | Upgrade
|
| Free Cash Flow | -7.04 | -7.04 | -6.4 | -6.3 | -3.71 | -3.02 | Upgrade
|
| Free Cash Flow Margin | -360.80% | -360.80% | -439.99% | -2130.85% | -374.92% | -241.71% | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | Upgrade
|
| Cash Interest Paid | - | - | 0.02 | 0.18 | 0.03 | 0.02 | Upgrade
|
| Cash Income Tax Paid | -1.94 | -1.94 | -1.05 | -0.52 | -1.12 | -0.98 | Upgrade
|
| Levered Free Cash Flow | -4.42 | -4.42 | -3.19 | -4.37 | -2.2 | -1.42 | Upgrade
|
| Unlevered Free Cash Flow | -4.42 | -4.42 | -3.18 | -4.25 | -2.19 | -1.41 | Upgrade
|
| Change in Net Working Capital | -0.17 | -0.17 | -0.51 | 0.07 | -0.11 | -0.85 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.